[LGND] YoY Quarter Result on 30-Jun-2013 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
01-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- 307.42%
YoY- 368.68%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Revenue 19,521 18,418 10,608 9,580 5,742 7,463 5,838 22.26%
PBT -9,644 22,292 1,241 3,804 -3,728 -773 335 -
Tax -3,881 265 -47 110 338 141 625 -
NP -5,763 23,564 1,592 6,091 -2,267 -914 -283 65.17%
Tax Rate - -1.19% 3.79% -2.89% - - -186.57% -
Total Cost 25,284 -5,146 9,016 3,489 8,009 8,377 6,121 26.64%
Ratio Analysis
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
NP Margin -29.52 127.94 15.01 63.58 -39.48 -12.25 -4.85 35.08%
Per Share
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
EPS -0.28 1.19 0.08 0.30 -0.11 -0.05 -0.01 74.16%
EPS Diluted -0.28 1.11 0.07 0.30 -0.11 -0.05 -0.01 74.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.